Similar articles

• [Biochemical and clinical correlations in Parkinson's disease].

  Barbeau A. Barbeau A. Rev Neurol (Paris). 1972 Aug;127(2):253-64. Rev Neurol (Paris). 1972. PMID: 4603361 Review. French. No abstract available.
• [Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa].

  Buscaino GA, Sori A, Campanella G. Buscaino GA, et al. Rev Neurol (Paris). 1972 Aug;127(2):301-2. Rev Neurol (Paris). 1972. PMID: 4666634 French. No abstract available.
• The role of the adrenergic system in the action of L-DOPA on brain serotonin.

  Algeri S, Cerletti C. Algeri S, et al. Adv Biochem Psychopharmacol. 1974;10:257-9. Adv Biochem Psychopharmacol. 1974. PMID: 4846542 No abstract available.
• The probenecid test in Parkinson's disease.

  Lakke JP, Korf J, Hoorntje S, Schut T, van Praag HM. Lakke JP, et al. Psychiatr Neurol Neurochir. 1973 Mar-Apr;76(2):139-46. Psychiatr Neurol Neurochir. 1973. PMID: 4700931 No abstract available.
• Parkinson's disease: from brain homogenate to treatment.

  Hornykiewicz O. Hornykiewicz O. Fed Proc. 1973 Feb;32(2):183-90. Fed Proc. 1973. PMID: 4143953 Review. No abstract available.